###### Strengths and limitations of this study

-   This national multicentre cross-sectional study included non-nephrologist physicians from the three major healthcare providers: Abu Dhabi Health Services Company, Dubai Health Authority and Ministry of Health, United Arab Emirates.

-   The questionnaire items were based on the internationally widely accepted chronic kidney disease clinical practice guidelines for the Evaluation and Management of Chronic Kidney Disease (KDIGO).

-   The small size of the study and the possibility that some physicians\' responses might have been based on their knowledge rather than on their actual practice may limit the generalisability of the findings.

Introduction {#s1}
============

Chronic kidney disease (CKD) is a global public health problem.[@R1] In developing countries, including the United Arab Emirates (UAE), CKD is widespread because of the increasing prevalence of diabetes, hypertension and coronary artery disease.[@R2] In the UAE, the age-adjusted prevalence of diabetes is 19% of the population and an additional 12.5% of the population has impaired glucose tolerance.[@R7] In alignment with the epidemic of metabolic and cardiovascular diseases (CVDs), the prevalence of CKD in UAE is estimated to be very high.[@R6]

Early CKD is relatively asymptomatic but is nevertheless associated with serious comorbidities and increased cardiovascular mortality.[@R11] So it is important to provide quality care for early CKD in order to prevent death and avoid the need for dialysis and kidney transplantation.[@R12] [@R13] Owing to the growing number of patients with CKD and the limited number of nephrologists, physicians in primary and specialised healthcare (SHC) have to play an important role in providing this quality care to patients with CKD.[@R12]

Providing quality CKD care includes regular screening of high-risk individuals, such as patients with diabetes, hypertension or CVD,[@R13] [@R14] using the more accurate CKD diagnostic tools, such as estimated glomerular filtration rate (eGFR) and the urine albumin/creatinine ratio (ACR). Quality CKD care also requires implementation of effective preventive strategies, such as drugs that block the renin−angiotensin system, which can delay or prevent CKD complications.[@R13] [@R14]

Despite two decades of widely accepted CKD clinical practice guidelines, such as the Kidney Disease Outcomes Quality Initiative (KDOQI) and continuing medical education for physicians, recent reports from many affluent developed countries indicate that CKD care remains suboptimal.[@R15] [@R16] The deficiencies in CKD care are expected to be more serious in developing nations that lack sufficient funds for quality CKD care,[@R17] [@R18] and there is little or no information about the CKD care in affluent developing countries with well-funded healthcare systems, such as the UAE.

For many years, the UAE healthcare authorities have had a modern healthcare service that is covered by a compulsory health insurance scheme for the entire population.[@R19] Access to pharmacy services and modern diagnostic laboratory support are also available at the point of care.[@R20] [@R21] Nevertheless, awareness of patients and physicians of CKD is essential for effective CKD clinical practice.[@R22]

The aim of this study was to explore how non-nephrologist physicians screen, diagnose and manage CKD in the UAE, which has seen a dramatic rise in the prevalence of CKD.[@R8]

Methods {#s2}
=======

This is a cross-sectional study based on an electronic survey of physicians. A 28-item self-administered questionnaire was designed to determine the physicians\' approach to identification (8 questions) and management (11 questions) of patients with CKD (see online [supplementary file](#SM1){ref-type="supplementary-material"}). Nine other questions were used to identify the demographics and characteristics of the study participants. The themes of the questions were based on KDIGO recommendations and guidelines.[@R13] The questionnaire was reviewed by three nephrologists and four internists at the College of Medicine, UAE University (UAEU) to assess the face validity of the survey items and to provide feedback on the clarity and conciseness of the questionnaire. We then posted the questionnaire using an online survey programme that allows respondents to answer the questions but does not allow duplication of responses. The link to the survey, along with a cover letter, was emailed to a test group of primary healthcare (PHC) physicians (n=4) and attending physicians of internal medicine (n=5), Al Ain, UAE. No problems were identified in the pilot study and therefore no changes were made to the questionnaire. The link to the online survey and the cover letter were then sent by electronic mail to the Dubai branch of the Emirates Medical Association (EMA), and to the medical directors within Abu Dhabi health services (SEHA) institutes for forwarding to their member physicians. The directors could decide whether to forward the survey, and physicians\' participation was voluntary. Responses were anonymous and no identifying data were collected. Three reminders were sent on our behalf by the EMA Office and the medical directors of Abu Dhabi health services. As an incentive, participants were offered a workshop to discuss the results of the questionnaire and CKD management. Responses were collected from 26 September 2013 to 5 March 2014. The survey\'s first page contained information on the rationale of the study and statements ensuring the confidentiality of respondents. The participants were given the choice to decline or to proceed to answer the survey questions. The survey questions allow for no response as an option for every question, and the participants can stop participation at any time. Completion of the survey signified informed consent.
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Statistical methods {#s2a}
-------------------

We summarised the questionnaire responses using descriptive statistics. The proportions were calculated based on the total number of respondents for each question. The χ^2^ or Fisher\'s exact test was used to assess the independence of categorical variables, as appropriate. We employed logistic regression analysis to examine the variations in the practice of CKD care by locality and the provider characteristics as independent variables. The dependent variables were the screening for CKD in patients with hypertension, diabetes mellitus or CVD and in elderly patients, the use of eGFR and ACR in the diagnosis of CKD, and the initiation of treatment with ACE inhibitors. All variables with a value of p\<0.1 in the univariate analysis were entered into a stepwise multiple regression analysis. Analyses were performed using SPSS V.18.0 (IBM, Chicago, Illinois, USA) and p values \<0.05 were considered statistically significant.

Results {#s3}
=======

Participant characteristics {#s3a}
---------------------------

We do not know the number of physicians who received the questionnaire, so we could not compute the exact response rate. Based on the number of physicians with active email accounts registered on the website of the Dubai branch of EMA and those practising at participating Abu Dhabi health services institutes, up to 536 physicians could have received the email invitation for participation in the study. We received responses from 185 physicians (40.5% female), giving a response rate of at least 34%. We excluded 26 questionnaires: 3 incomplete questionnaires, 6 that were from non-physicians (2 nurses, 3 dentists and 1 non-clinician), 13 that were from nephrologists and 4 from physicians who had limited or no contact with patients (3 radiologists and 1 pathologist). Of the remaining 159 respondents, the 135 physicians who declared that they see patients with CKD in their practice were used in the analysis ([figure 1](#BMJOPEN2015010832F1){ref-type="fig"}).

![Flow diagram of exclusions and inclusions. CKD, chronic kidney disease.](bmjopen2015010832f01){#BMJOPEN2015010832F1}

Of the 135 respondents, 72 (41.5%) were from PHC facilities and the others were from SHC institutions, including all medical subspecialties that encounter kidney patients except nephrologists. The geographical distribution of respondents is shown in [figure 2](#BMJOPEN2015010832F2){ref-type="fig"}. Dubai and the Northern Emirates were classified as locality A (60.7% of respondents), whereas Abu Dhabi and Al Ain areas were labelled as locality B (39.3% of respondents). The overall median age of the physicians was 45 years (25−60), of whom 66% of them had been practising for more than 5 years in the UAE ([table 1](#BMJOPEN2015010832TB1){ref-type="table"}).

###### 

The characteristics of the practice of 135 non-nephrologist physicians who see patients with CKD at PHC or SHC facilities in the United Arab Emirates

                                   Total       PHC vs SHC facilities           
  -------------------------------- ----------- ----------------------- ------- -------
  Affiliation of physician         100 (135)   40.0                    60.0    
  Age (years)                      45          45                      45      0.74
  Sex (M/F)                        76/55       23/30                   53/25   0.005
  Locality (A/B)                   82/53       29/25                   53/28   0.21
  Service \>5 years                66.4        70.4                    63.8    0.46
  See \>5 patients with CKD/week   40.7        35.2                    44.4    0.29
  Use CKD guidelines               63.4        75.5                    55.6    0.031
  Access to nephrology services    82.0        75.9                    86.1    0.14

CKD, chronic kidney disease; F, female; M, male; PHC, primary healthcare; SHC, secondary healthcare.
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Sixty-three per cent (n=85) reported using CKD guidelines and 82% (n=109) had access to nephrology consultation. CKD guidelines were being used more frequently by PHC physicians (75%; n=40) than by SHC physicians (56%; n=45; p=0.031). Over the past year, 41% of the physicians (n=55) had been seeing five or more patients with CKD per week ([table 1](#BMJOPEN2015010832TB1){ref-type="table"}).

Screening and diagnosis {#s3b}
-----------------------

[Table 2](#BMJOPEN2015010832TB2){ref-type="table"} shows the CKD care patterns among PHC and SHC physicians. Almost all respondents stated that they screen patients with hypertension or diabetes for CKD (94% and 96% of physicians, respectively), but fewer screen for CKD in patients with CVD (76%, p\<0.001) and elderly patients (68%, p\<0.001; [table 2](#BMJOPEN2015010832TB2){ref-type="table"}). Seventy-seven per cent of respondents use eGFR as a screening tool for CKD and 19.3% use serum creatinine alone. Fifty-nine per cent use ACR for measurement of proteinuria, 11% use 24-hour urine collection and 7% use urine dipstick. However, only 49.6% use both eGFR and ACR in the diagnosis of CKD, while 38% of the respondents rely on nephrology consultations to confirm the diagnosis of CKD.

###### 

The pattern of chronic kidney disease diagnosis and management of 135 non-nephrologist physicians at PHC and SHC facilities in the United Arab Emirates

                                  Total   PHC vs SHC facilities          
  ------------------------------- ------- ----------------------- ------ -------
  Screening                                                              
   HTN                            94.1    98.1                    91.4   0.10
   DM                             96.3    98.1                    95.1   0.35
   CVD                            75.6    79.6                    72.8   0.37
   Elderly (\>60 years)           68.1    75.9                    63.0   0.11
  Diagnostic tools                                                       
   For level of kidney function                                          
   Serum creatinine alone         19.3    11.1                    24.7   0.051
   eGFR                           77.0    87.0                    70.4   0.024
  For proteinuria                                                        
   ACR                            59.3    63.0                    56.8   0.47
   24-hour urine collection       11.1    09.3                    12.1   0.57
   Urine dipstick alone           06.7    03.7                    08.6   0.26
  Referral to nephrology                                                 
   Level of kidney function                                              
    eGFR\<60                      43.9    43.4                    44.3   0.80
    eGFR\<45                      14.4    18.9                    11.4   0.26
    eGFR\<30                      22.7    26.4                    20.3   0.45
    Cr\>150                       12.1    05.7                    16.5   0.055
    Cr\>300                       01.5    01.9                    01.3   0.70
  Proteinuria                                                            
   With or without haematuria     70.2    61.7                    76.1   0.10
   Only with haematuria           29.8    38.3                    23.9   0.10
  Treatment                                                              
   Offer antilipid                65.9    70.4                    63.0   0.37
   Weight reduction               67.4    79.6                    59.3   0.013
   Smoking cessation              80.7    85.2                    77.8   0.28
   BP goal \<130/80               85.5    96.3                    77.9   0.003
   ACEI initiation                76.3    87.0                    69.1   0.017

ACEI, ACE inhibitors; ACR, albumin/creatinine ratio; BP, blood pressure; Cr, creatinine; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertension; PHC, primary healthcare; SHC, secondary healthcare.

Referral {#s3c}
--------

An eGFR\<60 mL/min/1.73/m^2^ or a serum creatinine \>150 μmol/L prompts 55% of the respondents to refer their patients to nephrology. Fifty-nine per cent consider significant proteinuria an indication for referral while 25% refer if there is associated haematuria.

Management {#s3d}
----------

Ninety-six per cent of the respondents consider CKD a risk factor for CVD, but only 66% of them provide antilipid treatment, 67% prescribe weight reduction and 80% recommend smoking cessation to their patients. Eighty-five per cent consider a blood pressure control ≤130/80 as an optimal target, 13% use a blood pressure target of \>130/80 and 1.5% have no specific blood pressure target. Seventy-six per cent initiate ACE inhibitors or angiotensin receptor blockers (n=103), but in practice 61% of those who offer ACE inhibitors estimated that at least half of their patients were on these medications.

Association of CKD care with physician and practice characteristics {#s3e}
-------------------------------------------------------------------

Univariate logistic regression analysis is shown in [table 3](#BMJOPEN2015010832TB3){ref-type="table"}. The PHC physicians were more familiar than SHC physicians with the use of eGFR in the diagnosis of CKD (OR=2.8; 95% CI 1.1 to 7.1; p=0.028). However, physicians working in locality B were four times more likely to use eGFR than those in locality A (OR=4.5; 95% CI 1.6 to 12.5; p=0.005). Multivariate regression analysis confirmed that both the locality (OR=4.18; p=0.007, [table 4](#BMJOPEN2015010832TB4){ref-type="table"}) and PHC practice (OR=2.59; p=0.05, [table 4](#BMJOPEN2015010832TB4){ref-type="table"}) are independently associated with the use of eGFR. In general, the use of ACR in the diagnosis of CKD was infrequent in both healthcare localities (59%, OR=1.08; p=0.83, not significant).

###### 

Univariate logistic regression analysis of the quality of CKD care in relation to respondents\' characteristics

                                                                                               OR     95% CI          p Value
  -------------------------------------------------------------------------------------------- ------ --------------- ---------
  Screening for CKD in patients with hypertension, diabetes or CVD and those aged \>60 years                          
   Age                                                                                         1.07   0.53 to 2.17    0.86
   Female gender                                                                               1.09   0.54 to 2.21    0.81
   Locality B                                                                                  1.47   0.72 to 2.99    0.29
   PHC practice                                                                                2.02   0.98 to 4.16    0.06
   Duration of practice                                                                        1.42   0.69 to 2.92    0.35
   Use CKD guidelines                                                                          1.18   0.58 to 2.39    0.65
   Access to nephrology                                                                        0.83   0.34 to 2.02    0.68
  Use of eGFR                                                                                                         
   Age                                                                                         0.80   0.35 to 1.82    0.59
   Female gender                                                                               1.72   0.73 to 4.02    0.21
   Locality B                                                                                  4.46   1.59 to 12.51   0.005
   PHC practice                                                                                2.83   1.12 to 7.14    0.028
   Duration of practice                                                                        0.76   0.317 to 1.83   0.54
   Use CKD guidelines                                                                          1.85   0.82 to 4.17    0.14
   Access to nephrology                                                                        1.19   0.41 to 3.50    0.75
  Use of ACR                                                                                                          
   Age                                                                                         1.39   0.68 to 2.84    0.37
   Female gender                                                                               2.01   0.97 to 4.17    0.06
   Locality B                                                                                  1.08   0.53 to 2.18    0.83
   PHC practice                                                                                1.29   0.64 to 2.62    0.48
   Duration of practice                                                                        1.23   0.60 to 2.55    0.57
   Use CKD guidelines                                                                          1.41   0.70 to 2.87    0.34
   Access to nephrology                                                                        1.22   0.49 to 3.02    0.67
  Initiation of ACEI                                                                                                  
   Age                                                                                         0.72   0.32 to 1.63    0.43
   Female gender                                                                               1.83   0.76 to 4.39    0.18
   Locality B                                                                                  2.33   0.96 to 5.67    0.06
   PHC practice                                                                                3.00   1.19 to 7.55    0.02
   Duration of practice                                                                        1.60   0.70 to 3.66    0.26
   Use CKD guidelines                                                                          2.03   0.907 to 4.54   0.08
   Access to nephrology                                                                        1.73   0.54 to 5.49    0.35
  Global CKD Care Score                                                                                               
   Age                                                                                         0.95   0.47 to 1.91    0.88
   Female gender                                                                               1.60   0.79 to 3.21    0.19
   Locality B                                                                                  2.15   1.06 to 4.35    0.03
   PHC practice                                                                                2.29   1.13 to 4.62    0.02
   Duration of practice                                                                        1.34   0.65 to 2.75    0.43
   Use CKD guidelines                                                                          2.31   1.12 to 4.74    0.02
   Access to nephrology                                                                        0.89   0.37 to 2.17    0.80

ACEI, ACE inhibitors; ACR, albumin/creatinine ratio; CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; locality B refers to Abu Dhabi and Al Ain areas; PHC, primary healthcare.

###### 

Multivariate logistic regression analysis of the quality of CKD care in relation to respondents\' characteristics

                                                                                               OR     95% CI          p Value
  -------------------------------------------------------------------------------------------- ------ --------------- ---------
  Screening for CKD in patients with hypertension, diabetes or CVD and those aged \>60 years                          
   PHC practice                                                                                2.02   0.98 to 4.16    0.06
  Use of eGFR                                                                                                         
   Locality B                                                                                  4.18   1.47 to 11.86   0.007
   PHC practice                                                                                2.59   1.00 to 6.69    0.05
  Use of ACR                                                                                                          
   Female gender                                                                               2.01   0.97 to 4.17    0.06
  Initiation of ACEI                                                                                                  
   PHC practice                                                                                2.58   1.01 to 6.58    0.02
  Global CKD Care Score                                                                                               
   PHC practice                                                                                2.29   1.13 to 4.62    0.02

ACEI, ACE inhibitors; ACR, albumin/creatinine ratio; CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; locality B refers to Abu Dhabi and Al Ain areas; PHC, primary healthcare.

PHC physicians were more familiar with the initiation of therapy with ACE inhibitors than SHC physicians (OR=3.0; p=0.02). Familiarity was also associated with the use of CKD clinical guidelines (OR=2.0; p=0.08), but multivariate regression analysis shows a strong association with PHC practice (OR=2.58; p=0.02, [table 4](#BMJOPEN2015010832TB4){ref-type="table"}) but not with the use of CKD clinical guidelines.

We included eight dichotomous (done or not done) items with face validity to examine the practices of diagnosis and management of CKD ([figure 3](#BMJOPEN2015010832F3){ref-type="fig"}). We found that PHC and SHC physicians differ in their use of eGFR and ACE inhibitors ([figure 3](#BMJOPEN2015010832F3){ref-type="fig"}). An overall CKD care score was computed by adding the eight items: only 32 physicians (23.7%) obtained a score of 8/8. The multivariate regression analysis shows that the PHC physicians, irrespective of the healthcare locality and the use of CKD guidelines, had better performance than SHC physicians (OR=2.29; 95% CI 1.13 to 4.62; p=0.02, [table 4](#BMJOPEN2015010832TB4){ref-type="table"}).

![The performance of physicians at PHC and SHC facilities in screening, diagnosis and treatment of CKD. ACEI, ACE inhibitors; ACR, albumin/creatinine ratio; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertention; PHC, primary healthcare; SHC, specialised healthcare.](bmjopen2015010832f03){#BMJOPEN2015010832F3}

Discussion {#s4}
==========

Our findings indicate that provision of CKD care by non-nephrologists to non-dialysis-dependent patients is suboptimal in the UAE but comparable to some developed countries. Despite the high prevalence of CKD in the region,[@R2] [@R9] [@R13] a substantial proportion of responding physicians do not screen for CKD in elderly patients and in patients with CVDs, who are at high risk for CKD. This lack of appreciation of CKD risk factors by physicians and their dependence on less accurate methods, such as serum creatinine alone or urine dipstick for diagnosis of CKD, could contribute to delay in the diagnoses of CKD and to suboptimal CKD care.[@R23] The eGFR and urinary ACR are recommended because of their greater sensitivity and precision in detecting early stages of CKD, and their more effective prediction of progression to kidney failure or cardiovascular death.[@R13] This under usage of ACR and eGFR for diagnosis of CKD could be due to the physicians\' unfamiliarity with these diagnostic tools or the absence of local laboratory and clinical protocols for their use in routine clinical practice.[@R26] The rare use of ACR indicates a notable deficiency in the physicians\' familiarity with the diagnostic tools for identification of CKD.[@R13] [@R27] Referral to nephrologist services is usually indicated when eGFR is \<30 mL/min 1.73/m^2^.[@R13] The preference for early referral reported in this study may indicate that non-nephrologist physicians are uncertain of how to manage patients with CKD.[@R13] [@R25] This notion is supported by the finding that about one-fourth of physicians do not initiate treatment with ACE inhibitors for patients with CKD.

The perceived suboptimal CKD care in this study is in agreement with recent laboratory evidence of a high frequency of undocumented CKD in the UAE and a delay in nephrology consultations.[@R20] Our study findings indicate that PHC facilities in the UAE provide better quality CKD care than non-nephrology SHC clinics ([figure 3](#BMJOPEN2015010832F3){ref-type="fig"}). The ease of access to nephrology consultation at SHC facilities could contribute to this discrepancy in the practices of CKD care.[@R21] [@R29] Also, the competing demands of patients with multiple comorbidities in SHC would prioritise down CKD care. Other factors related to the healthcare system (eg, insurance cover, practice style and cultural factors) are also potential barriers to optimal delivery of CKD care.[@R22] [@R29]

The approach for optimal CKD care should be multidisciplinary and focus on early identification and management of CKD in patients at high risk.[@R32] [@R33] This strategy might need the establishment of specialised CKD clinics and implementation of local protocols for CKD care.[@R34] Therefore, guidance by healthcare authorities is needed to improve the quality of CKD care in the UAE. A focused national public health programme for CKD care similar to the programmes that have proven their efficacy, such as those for tuberculosis, hypertension and diabetes, should be considered.[@R10]

Despite vigorous efforts to generate a robust physician response rate, the small size of our sample limits the generalisability of the findings. It is likely that some of the targeted physicians were not monitoring their emails,[@R38] but we do not know how much this contributed to the low response rate. It is also possible that physicians with a heavy workload may not have had the time to complete the survey.[@R39] A low response rate could result in overestimation or underestimation of CKD awareness in the UAE. However, the per cent distribution of respondents in the relevant specialties working in SHC (60%) and PHC (40%) reflects the corresponding percentages in the country, and thus the non-response is most likely random.[@R40] The other limitation is that while the study focused on describing the patterns of management of patients with CKD, some physicians might have responded based on their knowledge rather than on their actual practice. Moreover, they may not have accurately recalled their practice patterns, or may have attempted to provide what they perceived as the correct answer. Therefore, the study results might have underestimated the deficit in the quality of CKD care. Interviewing physicians and patients with CKD and reviewing medical records might provide additional insight into CKD care in the UAE.

In conclusion, although the study finding indicates deficiencies in the provision of early CKD care, the current state of CKD care remains largely unknown in the UAE, which has a large CKD population. We identified physicians\' unawareness of CKD risk factors and unfamiliarity with recommended CKD diagnostic tools and treatment as important shortcomings. Implementation of a specialised primary CKD healthcare programme could overcome these deficiencies.
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